Products for female urinary incontinence
Patients considering undergoing a procedure that involves implantation of a surgical mesh for the treatment of urinary incontinence should be aware of the possible adverse events linked to these procedures, which include but are not limited to:
• postoperative hematoma, seroma, abscess or fistula formation, or scarring which may occur following the implant procedure
• urinary retention, bladder outlet obstruction and other voiding dysfunctions
• perforations or lacerations of vessels, nerves, bladder, bowel, urethra, or any viscera, which may occur during or after the implantation procedure
• irritation at the operative wound site which may elicit a foreign body response that leads to wound dehiscence, inflammation and/or infection
• extrusion of the implanted mesh through vaginal epithelium or erosion into surrounding viscera and/or mucosa
• inflammation, sensitization, acute and/or chronic pain, dyspareunia, dysuria, scarification, contraction, device migration and failure of the procedure resulting in recurrence of incontinence.
Please be aware that adverse events are not limited to those listed above.
Always ask your physician to provide you with comprehensive clinical data on this type of surgeries.